WZR supported Client C, one of the world‘s largest manufacturer of radioactive components for medical purposes, in the following process:
- Sold 50% of shares of its Chinese production company in East China to a major Chinese listed company in the same business area.
- Trough the share transfer, the production company in East China has been transformed to a German-Chinese Joint Venture.
Result:
Client C got a strong Chinese partner for fast growth on the Chinese market
Vor der Anteilsuebertragung und nach der Anteilsuebertragung
WZR Services:
